HealthpointCapital Acquires ImmersiveTouch, Inc., a Leading Extended Reality Surgical Platform
SAN DIEGO and CHICAGO, June 30, 2025 /PRNewswire/ — HealthpointCapital, the leading private equity firm focused exclusively on musculoskeletal healthcare, today announced the acquisition of a majority stake in ImmersiveTouch, Inc. (“ImmersiveTouch” or the “Company”). ImmersiveTouch‘s ImmersiveView™ platform is a... Read More →
Neurent Medical Announces Expanded Access Following Cigna Policy Update for NEUROMARK®
Effective September 15, CPT 31242 is no longer considered experimental, clearing an important barrier for ENT physicians treating chronic rhinitis. GALWAY, Ireland, June 30, 2025 /PRNewswire/ — Neurent Medical, a leader in non-surgical treatments for chronic rhinitis, today announced that... Read More →
STENTiT Enrolls First Patient in Clinical Trial Evaluating a Novel Stent with Regenerative Properties to Support Limb Preservation
EINDHOVEN, The Netherlands – June 26, 2025 – STENTiT, a pioneering medical device company, developing a novel class of stents with regenera6ve proper6es, today announced the successful implanta6on of its Resorbable Fibrillated Scaffold (RFS). As part of the VITAL-IT 1... Read More →
Emerging technologies in healthcare, part 7: Lattice Medical
Julien Payen, cofounder and CEO of Lattice Medical, describes the company’s 3D-printed, resorbable breast implant that uses a patient’s own fat to regenerate natural breast tissue after a mastectomy. Lattice Medical has created a 3D-printed, resorbable implant called MATTISSE, designed... Read More →
Amplified Sciences Secures Exclusive Patent License from UCSF for Cutting-Edge Diagnostic Technology
West Lafayette, Ind. (June 23, 2025) – Amplified Sciences announced today that it has secured an exclusive global license to a patent from the University of California, San Francisco (UCSF) that helps enable PanCystPro, the company’s first product offered as... Read More →
PharmaJet® and Immuno Cure Sign Agreement for Clinical Development of a Needle-free HIV Therapeutic DNA Vaccine
GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, today announced that it has entered into an agreement with Immuno Cure, a prominent developer of DNA vaccines. Under... Read More →
Bloom Standard expands access to infant ultrasound for faster diagnosis and better outcomes
Patient Stories: How MedTech Innovator alumni are transforming lives At MedTech Innovator, we empower healthtech companies to bring groundbreaking solutions to patients in need. Our Patient Stories series highlights the real-world clinical impact of the companies we support—showcasing how their... Read More →
Neuspera Medical Receives FDA Approval for First Integrated Sacral Neuromodulation (iSNM) System for Urinary Urge Incontinence
SAN JOSE, Calif., June 18, 2025 /PRNewswire/ — Neuspera® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, today announced that the U.S. Food and Drug Administration (FDA) has approved its integrated sacral neuromodulation (iSNM) system... Read More →
Mount Sinai adopts Flosonics wearable ultrasound device
Flosonics announced today that Mount Sinai Hospital has adopted FloPatch, its wireless Doppler ultrasound device. Mount Sinai (New York), one of the top hospitals in the U.S., adopted FloPatch in its surgical and transplant intensive care unit (ICU). The company... Read More →
Backed by $2 Million, Droplet IV is Set to Launch its Revolutionary Automatic IV-Line Flushing Device in EU & US in 2026
Copenhagen, Denmark – June 10, 2025 – Droplet IV today announced the successful completion of a $2 million funding round to enable launch of its first automatic IV-line flushing device in the EU and US markets. The device addresses a... Read More →